Brad D. Manion

Brad D. Manion

Auto-generated profile, based on publicly available information

Brad D. Manion

Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2005 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CZChun-Min Zeng
Chun-Min Zeng
BMBrad D. Manion
Brad D. Manion
ABAnn Benz
Ann Benz
AEAlex S Evers
Alex S Evers
CZCharles Zorumski
Charles Zorumski
DCDouglas Covey
Douglas Covey

1 February 2007 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
Gustav AkkGustav Akk
Gustav Akk
PLPing Li
Ping Li
BMBrad D. Manion
Brad D. Manion
AEAlex S Evers
Alex S Evers
JSJoe Henry Steinbach
Joe Henry Steinbach
We have examined α1β2γ2L GABAA receptor modulation by the endogenous steroids allopregnanolone (3α5αP), pregnenolone sulfate, and β-estradiol in the absence and presence of ethanol. Coapplication of 0.1 to 1% (17-170 mM) ethanol influenced receptor modulation by 3α5αP but not that by pregnenolone sulfate or β-estradiol. One of the three kinetic effects evident in channel potentiation by 3α5αP, prolongation of the longest-lived open time component (OT3), was affected by ethanol with the midpoint of its dose-response curve moved to lower steroid concentrations by 2 orders of magnitude without significantly affecting the maximal effect. Manipulations designed to affect the ability of 3α5αP to prolong OT3 also affected OT3 prolongation in the presence of ethanol. A mutation to the γ2 subunit, which reduces the ability of 3α5αP to prolong OT3, also reduces the interaction between ethanol and 3α5αP. And the presence of the competitive steroid antagonist (3α,5α)-17-phenylandrost-16-en-3-ol (17-PA) diminishes the positive interaction between ethanol and 3α5αP on the GABAA receptor. Together, the findings suggest that steroid interactions with the classic steroid binding site underlie the effect seen in the presence of ethanol, and that ethanol acts by increasing the affinity of 3α5αP for the site. Tadpole behavioral assays showed that the presence of 3α5αP at a concentration ineffective at causing changes in tadpole behavior shifted the ethanol dose-response curve for loss of righting reflex to lower concentrations and that this effect was neutralized by coapplication of 17-PA with 3α5αP.

19 April 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ESEva Stastna
Eva Stastna
KKKathiresan Krishnan
Kathiresan Krishnan
BMBrad D. Manion
Brad D. Manion
ATAmanda Taylor
Amanda Taylor
NRNigam P. Rath
Nigam P. Rath
DCDouglas Covey
Douglas Covey
This study addresses the hypothesis that the lack of anesthetic activity for (3α,5α)-3-hydroxypregn-16-ene-11,20-dione (Δ16-alphaxalone) is explained by the steroid Δ16 double bond constraining the steroid 20-carbonyl group to a position that prevents it from favorably interacting with γ-aminobutyric acid type A (GABAA) receptors. A series of Δ16 and Δ17(20) analogues of Δ16-alphaxalone was prepared to evaluate this hypothesis in binding, electrophysiological, and tadpole anesthesia experiments. The results obtained failed to support the hypothesis. Instead, the results indicate that it is the presence of the C-21 methyl group in Δ16-alphaxalone, not the location of the constrained C-20 carbonyl group, that prevents Δ16-alphaxalone from interacting strongly with the GABAA receptor and having anesthetic activity. Consistent with this conclusion, a Δ17(20) analogue of Δ16-alphaxalone without a C-21 methyl group was found to be very similar to the anesthetic steroid (3α,5α)-3-hydroxypregnane-11,20-dione (alphaxalone) with regard to time of onset and rate of recovery from anesthesia when administered to mice by tail vein injection.

31 July 2025 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
ZSZhixin Sun
Zhixin Sun
JGJacqueline M. Godbe
Jacqueline M. Godbe
AZAlexander Zheleznyak
Alexander Zheleznyak
BMBrad Manion
Brad Manion
JHJunhao Hu
Junhao Hu
MSMonica Shokeen
Monica Shokeen
Radiological imaging plays an indispensable role in both preclinical and clinical studies of multiple myeloma (MM). However, manual quantification in longitudinal small animal PET/CT is limited by annotator bias, signal artifacts from urinary/fecal excretion, and voxel misalignment due to non-rigid registration. To address these challenges and improve characterization of tumor biology, we developed a semi-automated PET/CT quantification pipeline targeting defined regions of interest (ROIs) within the bone marrow-rich mouse skeleton, achieving sub-organ spatial resolution, including in anatomically complex sites such as the pelvis. We applied this MM-specific preclinical pipeline to analyze tumor distribution in a longitudinal molecular PET study using an immunocompetent mouse model of skeletally disseminated MM. An Attention U-Net was trained to segment the thoracolumbar spine, pelvis and pelvic joints, sacrum, and femurs from 2D CT slices. A custom algorithm masked spillover signal from physiological excretion, and a PCA-based projection was used to map tumor distribution along the skeletal axis. Quantification metrics included mean and maximum standardized uptake values (SUVmean, SUVmax) from PET and Hounsfield Units (HU) from CT to assess tumor burden, spatiotemporal tumor distribution, and bone involvement. Tumor burden localized preferentially to skeletal regions near joints. Using precise CT-based alignment (DICE = 0.966 ± 0.005), we detected early disease progression and aggressive phenotypes. A marked increase in tumor uptake was observed by day 18 post-implantation, with significant SUVmean increases in the spine (p = 0.012), left/right femurs (p = 0.007/0.006), pelvis and pelvic joints (p = 0.018), and sacrum (p = 0.02). Notably, sex-based differences were identified: female mice showed greater bone loss near the hip joint at later stages, with significant HUmean reductions at days 25 (p = 0.008) and 32 (p = 0.002). This pipeline enables reproducible, anatomically precise quantification of region-specific trends in MM progression, including joint-specific lesion tropism and sex-based differences, from longitudinal PET/CT scans. By mitigating common challenges such as excretion artifacts and inconsistent mouse positioning, our approach overcomes limitations of manual analysis and enhances evaluation of tumor biology and treatment response in preclinical models of bone-involved cancers.